p53 expression predicts dismal outcome for medulloblastoma patients with metastatic disease.

Abstract excerpt

Medulloblastoma (MB) is the most common malignant primary brain tumour in childhood. Metastatic disease (M+) at diagnosis is the most important negative prognostic clinical marker and, despite craniospinal irradiation and intensive chemotherapy, it remains one of the leading causes of treatment failure. To date, few clinical and biological data have been evaluated to obtain an additional prognostic profile for...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to beta Catenin
• Share to Cerebellar Neoplasms
• Share to Disease-Free Survival